Zimmer Biomet completed the acquisition of A&E Medical from Vance Street Capital for $250m.

Zimmer Biomet, a medical device company, completed the acquisition of A&E Medical, a manufacturer of medical devices, from Vance Street Capital, a private equity firm, for $150m in cash at closing and $100m in cash payable in 2021. "A&E Medical's high-growth business and innovative products are highly complementary to our current portfolio and will allow us to offer a comprehensive suite of sternal closure products, including rigid fixation, which has the potential to shift the standard of care and address a variety of unmet patient and surgical needs. This deal aligns with our active portfolio management strategy and the ongoing transformation of our business that will position Zimmer Biomet for long-term growth," Bryan Hanson, Zimmer Biomet President and CEO.